Its status as a biomarker of disease activity is well-known, but the serum ferritin/ESR ratio may be a more valuable biomarker than ferritin alone in differentiating MAS from new-onset sJIA [200,229,230]. Here, ESR1 is linked to macrophage activation syndrome.